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j.jegh.201bstract Background: Breast cancer (BC) is the most common cancer afflicting
Puerto Rican women and accounts for more cancer-related deaths in this population
than any other cancer.
Methods: Demographic, anthropometric, family history, and lifestyle data, as
well as DNA repair capacity (DRC), were compared in 465 BC cases and 661 controls.
Crude and multiple logistic regression-derived adjusted odds ratios were used as
indicators of the associations between BC and the variables under study.
Results: A low DRC level, aging (>61 years), family history of BC, and low educa-
tion level had statistically significant associations with increased BC risk. Endometri-
osis, full-term pregnancy at an earlier age, higher parity, hysterectomy before age
50, multivitamin and calcium intake, and longer duration of breastfeeding signifi-
cantly decreased BC risk.
Conclusions: This study discusses the major risk factors for BC in Puerto Rico (PR).
Because many of these findings represent modifiable risk factors, they can translate
into public health initiatives to lower BC risk. In addition, the possibility of using DRC
as a simple screening tool for BC risk is explored.
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Worldwide, the malignancy that occurs most fre-
quently in women is breast cancer (BC) [1]. In
2011, an estimated 230,480 new cases of invasive
BC were expected to be diagnosed in women in
the United States, along with 57,650 new cases of
non-invasive (in situ) BC [2].abia. Published by Elsevier Ltd.
creativecommons.org/licenses/by-nc-nd/4.0/).
206 L. Morales et al.Hispanics are the fastest growing minority in the
US, with 9% of the Hispanic population being Puerto
Ricans [3]. Although mainland and island Puerto Ri-
cans are included in the statistics of the US as part
of the Hispanic group, differences in risk factors
among mainland Puerto Ricans versus island Puerto
Ricans have been found-most notably, lower BC
incidence in the latter group [3,4]. Similarly, Naza-
rio et al. estimated the lifetime risk of Puerto Ri-
can women developing BC at 5.4% [5]; however,
reported lifetime BC risk in the US is 2.3 times high-
er: 12.5% [6]. The incidence of BC among island
Puerto Ricans has been increasing in recent years
[4,5]; this warrants investigation.
BC is the most prevalent of all cancers in Puerto
Rico (PR) and accounts for 30.3% of all female can-
cers [7]. BC also has the highest mortality of all
cancers in this population [7,8]. The most recent
data available through the Puerto Rico Cancer
Registry state that between 2005 and 2009, 1725
new BC cases were reported in PR [7]. Thus, there
is a need to pursue new ways to prevent, predict,
identify, and mitigate the impact of BC in the
Puerto Rican population.
Limited published data exist regarding the epi-
demiology of BC in PR [5,7], and most information
explores only incidence and mortality [5,7,8]. Due
to the multiethnic composition of this population,
which is an admixture of European, African, and
Amerindian ethnic groups [9], it is important to
study the risk factors that could make this popula-
tion less susceptible to developing BC than other
populations.
Because BC is a multifactorial disease that is a
result of the interplay between genetic, epigenetic
and lifestyle factors [10], the risk factors chosen in
this study reflect all those domains. The modifiable
risk factors under study represent risk factors that
had been studied previously in other populations.
In this study, the aim was to confirm their impact
on the population of PR. This may be the first re-
search to study those concurrently with genetic
(receptor status) and epigenetic factors.
Regarding the latter, DNA repair capacity (DRC)
was analyzed as a risk factor for BC. DRC is critical
for maintaining genomic integrity, minimizing DNA
mutations and replication errors [11]. Differences
in DRC among individuals partially explain intrinsic
sensitivities to mutagens and carcinogens [12]. In-
deed, a number of studies have shown that low
DRC correlates with higher cancer risk [13–15]. A
recent study with the same cohort of women
showed that, on an average, Puerto Rican women
with BC have a 60% reduction in DRC compared
with controls [15].In this study, the association of all these poten-
tial risk factors for BC in Puerto Rican women was
also evaluated. Elucidating these BC risk factors
will provide increased opportunities for BC preven-
tion and control [16].2. Materials and methods
2.1. Case control selection
Participants comprised of 1126 adult female Puerto
Rican residents, age 21 or older: 465 recently diag-
nosed BC cases and 661 without BC. Cases were pa-
tients who were: (1) recently diagnosed and
histopathologically confirmed primary breast carci-
nomas; and (2) treatment-naı¨ve – that is, they had
not received chemotherapy, radiotherapy, or blood
transfusions in the previous 5 years, as described
by Matta et al., 2012 [15]. Patients with a prior his-
tory of cancer or with BC secondary to other cancer
types were excluded. Controls were women (1)
whose mammogram was negative within the previ-
ous 6 months; (2) who had undergone a clinical
breast examination by a gynecologist or other phy-
sician; and (3) who had not received any blood
transfusions within the previous 5 years. Patients
were recruited as incident cases between 2006
and 2012 in collaborating private clinical practices,
and controls were recruited concurrently. The
sample obtained represented 83% of the 78 coun-
ties of PR.
2.2. Sample
The sample size was calculated utilizing CDCs Epi
Info 7.0; it was found that the current sample
would allow for a statistically significant odds ratio
(OR) as low as 1.7 when the percent exposed
among controls is 10% or higher (type I error = 0.05,
type II error = 0.20; power 80%).
2.3. Data collection
Cases and controls completed a written informed
consent, a HIPAA form, and participated in an
interview based on a seven-page epidemiological
questionnaire. Data gathered from the question-
naire included information on age, body mass index
(BMI), family history of cancer, genetic, gynecolog-
ical, hormonal, and environmental factors,
selected nutritional variables including multivita-
min and calcium intake, and other variables that
could provide an estimate of BC risk. The selection
of the potential predictors (exposures) under study
Factors associated with breast cancer in Puerto Rican women 207and the questions used were based on previously
published research on BC.1 This study was approved
by the Institutional Review Board (IRB) of the
Ponce School of Medicine and Health Sciences
and by the IRBs of participating clinics that had
such a body.
The research staff received proper training
regarding NIH Guidelines for the Study of Human
Subjects. A registered nurse interviewed each par-
ticipant and drew a blood sample for assessing DRC
(using a host-cell reactivation assay).
2.4. Host cell reactivation assay
The host cell reactivation assay was performed as
described by Matta et al., 2012 [15].
2.5. Statistical analysis
Data analyses were performed using the SPSS 17
statistical package (SPSS; Chicago, IL). BC cases
and controls were compared with regard to the dis-
tribution of selected exposures such as age, BMI,
family history of BC, irregular menses, breastfeed-
ing practices, intake of vitamins and calcium sup-
plements, and DRC level. DRC was categorized as
low, medium, or high using tertiles from the whole
sample. For the unadjusted analyses, cases were
compared with controls in terms of the selected
exposures (covariates). For categorical variables,
the odds ratio (OR) was used as a measure of asso-
ciation, and the 95% confidence interval of the OR
was utilized to assess the precision of this esti-
mate. The two-tailed Fishers exact test was calcu-
lated to measure the statistical significance of the
crude OR [17]. A P value 60.05 indicated statisti-
cally significant results.
Continuous variables, including those related to
age (oral contraceptive use, birth of first child,
hysterectomy, and oophorectomy) were catego-
rized. After using the Mantel and Haenszel
stratified analysis to explore confounding and
interactive effects among all variables in the study,
multiple logistic regressions were used to measure
the adjusted OR. Potential interactions with covar-
iates such as age groups, menopause, and parity
were further examined using multiple logistic
regressions, adjusting for all confounders simulta-
neously [17]. No important effect modifications1 Brintons Womens Interview Study of Health; Zieglers Asian-
American BC Study; Tuckers Family Studies Questionnaire;
Browns Population Health Study; Schairers BCDDP-Female
Questionnaire; Hayess Population Health Study; Anton-Culvers
Familial Breast and Ovarian Cancer Study; and Doodys X-ray
Technicians–Second Survey.or statistically significant interactions were found
during the analyses. To evaluate the association
between BC and selected variables, the analysis
was adjusted by age, BMI, family history of BC,
menopause, number of children, alcohol use,
smoking and vitamin use.3. Results
A total of 465 BC cases and 661 controls were ana-
lyzed in the study. The mean age (±SD) of women
with BC (range: 24–89 years) and controls (range:
21–87 years) was 56.4 ± 12.6 and 52.3 ± 12.5,
respectively (P < 0.001). Table 1 includes the
description of tumor characteristics among cases:
65.3% infiltrating ductal, 4.7% infiltrating lobular,
17.9% in situ ductal, 1.8% in situ lobular, and
9.8% mixed components. In terms of receptor status,
73.5% of the cases were estrogen receptor positive
(ER+), 66.9% were progesterone receptor positive
(PR+) and 76.8% were Her2 receptor negative
(Her2). In terms of ER and PR, a positive
receptor status indicates better prognosis and
more options of treatment available. A negative
Her2 receptor status indicates a less aggressive
cancer.
Table 2 includes the associations between BC
and gynecological variables. Having a history of
endometriosis decreased the risk of having BC by
39% (P = 0.039). Women who began menopause
after age 50 had a 41% greater risk of having BC
(P = 0.023), while, for women currently in meno-
pause, no statistical significance was shown
(P = 0.278). An inverse association between parity
status and cancer risk was also observed. The
adjusted odds ratio for P5 children reached 0.42
(P = 0.006) versus nulliparous women. Also, in an
analysis of parity on a continuous scale, it was
found that the risk of BC decreased by 11%
(OR = 0.89, P = 0.003) with each subsequent birth.
Furthermore, women who had their children at a
younger age, especially age 20–29, showed a 41%
lower risk of developing BC (OR 0.59, P = 0.011).
Oral contraceptives appeared to be associated with
a 38% decreased risk of BC, if they were used after
age 21 (P = 0.048). Hysterectomy (defined as the
surgical removal of the uterus) on a continuous
scale was not statistically significant. However,
women who had a hysterectomy between the ages
of 41 and 49 had a 56% lower risk of having BC
(P = 0.020). That reduced risk appeared to decline
by 1% with each year after hysterectomy
(P = 0.044). In terms of menopause hormone ther-
apy (MHT), it was found that BC postmenopausal
cases were 26% less likely to have used MHT than
Table 1 Description of tumor characteristics among
case subjects with breast cancer (BC).
Variable BC cases n (%)
Type of cancer
Infiltrating ductal 280 (65.3)
Infiltrating lobular 21 (4.9)
In situ ductal 77 (17.9)
In situ lobular 8 (1.9)
Mixed components 43 (10.0)
Missing #36
Receptor status
Estrogen
Positive 228 (73.5)
Negative 82 (26.5)
Unknown #155
Progesterone
Positive 208 (66.9)
Negative 103 (33.1)
Unknown#154
Her2
Positive 65 (23.2)
Negative 215 (76.8)
Unknown #185
Triple negative 41 (13.4)
Grade
Well differentiated 52 (14.6)
Moderately differentiated 189 (52.9)
Poorly differentiated 110 (30.8)
Unknown #114
208 L. Morales et al.controls (P = 0.001). Women who breastfed for
6 months or more had a 36% lower risk of develop-
ing BC (P = 0.057; borderline significance).
Table 3 shows the association of BC with other
selected variables. DRC as a continuous variable in-
creased the risk of women developing BC by 1.54
times. Women with low DRC levels (62.52%) had
17.3 times greater risk of developing BC in
their lifetime. Women with medium DRC levels
(2.53–5.36%) had 2.7 times greater risk of developing
BC compared with those with high DRC levels
(P5.37%). Both associations were statistically
significant (P < 0.001). Women 41–60 years of age
had 1.78 times greater risk of developing BC com-
pared with women 21–40 years of age (P = 0.036).
The remainder of Table 3 lists modifiable risk
factors and their impact on BC risk. Education level
was an important risk factor for BC in the study
population. Women with high school education
(9–12th grade) showed a slight increase in BC risk
of 1.3 times (P = 0.086), while those with only an
elementary school education (1st–8th grade) had
3.4 times greater risk of having BC (P = 0.003).Regarding marital status, widows had 2.1 times
greater risk of having BC (P = 0.039) than did mar-
ried women, followed by those who were divorced,
who were 2.6 times more likely to have BC
(P = 0.002). Smokers had 1.58 times the risk of hav-
ing BC (P = 0.066) than non-smokers. Those with a
family history of BC had twice the risk (P = 0.001)
of having BC in their lifetime. Women who had a
family history of any other cancer (not BC) had a
35% greater risk of having BC (P = 0.031). No statis-
tical association with BC was found regarding alco-
hol consumption and BMI.
Regarding vitamin consumption, 57.4% of
women reported taking vitamins. The odds of
currently taking vitamins was 50% lower in the BC
cases (P < 0.001), while consumption of vitamins
(5-year period) showed a decrease in BC risk by
40% (P < 0.001). In terms of multivitamin and
calcium intake, BC patients had 30% and 50% less
consumption than the control group, respectively
(P = 0.005, P < 0.001, respectively).4. Discussion
This study provides an overview of the major epi-
demiological factors for BC in PR using a sample
of women that includes 465 BC cases and 661 con-
trols. In this study, as in previous studies, it was
shown that high DRC protects women against BC;
a low DRC is a BC risk factor for the Puerto Rican
population. Previous studies have indicated simi-
lar results of an association of DRC with BC risk
[13,15] when analyzed as both a continuous and
categorical variable [18]. A broad discussion on
the usefulness of DRC level as a measure of BC
risk was recently published by Matta et al., 2012
[15].
Another molecular factor described is hormone
receptor status, which guides BC treatment choices
and indicates disease prognosis. In general, PR+
and ER+ are indicators of a good prognosis [19]
which, in this study, was of the majority of the
sample. In this study population, 13.4% of the sam-
ple was triple negative (ER, PR, Her2). Those
patients carry the worst prognosis and have a high
rate of relapse, especially within 3–5 years of ini-
tial treatment [20].
Reproductive factors were shown to modulate
BC in the study population. This study found that
having a diagnosis of endometriosis was protective
against BC. This may be due to the way endometri-
osis is treated; long-term estrogen-suppressive
pharmacological therapy decreases estrogen lev-
els, thus reducing BC risk [21]. MHT was also shown
to be important in modulating BC risk.
Table 2 Association of breast cancer (BC) with gynecological variables.
Variable BC cases Controls Crude OR (95% CI) Adjusted ORa (95% CI) P value
Pregnancy
Yes 397 552 1.12 (0.8, 1.7) 1.04 (0.7, 1.4) 0.824
No 68 109
Breast feeding total
Never 276 362 Referent Referent
0–5 months 138 244 0.82 (0.5, 1.2) 0.76 (0.5, 1.2) 0.244
P6 months 51 55 0.61 (0.4, 0.9) 0.64 (0.4, 1.0) 0.057
Parity status
Nulliparous 68 109 Referent Referent
1–2 children 185 321 0.25 (0.1, 0.5) 0.36 (0.2, 0.7) 0.003
3–4 children 159 201 0.24 (0.1, 0.4) 0.34 (0.2, 0.6) 0.001
P5 children 44 18 0.32 (0.2, 0.6) 0.42 (0.2, 0.8) 0.006
# Missing (21)
Age at first live birth
619 82 88 1.14 (0.8–1.6) 0.59 (0.4, 0.9) 0.011
20–29 242 365 0.76 (0.5–1.2) 0.63 (0.4, 1.0) 0.075
P30 63 85 Referent Referent
# Missing (201)
Menarche
612 245 378 0.85 (0.7, 1.1) 0.88 (0.7, 1.2) 0.372
P13 216 282
# Missing (5)
Endometriosis
Yes 26 68 0.52 (0.3, 0.8) 0.61 (0.3, 1.0) 0.039
No 438 590
# Missing (4)
Age oophorectomy
640 35 54 0.84 (0.4, 1.7) 0.79 (0.3, 1.5) 0.283
41–49 37 53 1.12 (0.5, 2.5) 0.95 (0.3, 1.9) 0.635
P50 20 26 Referent Referent
# Missing (901)
Menopause
Yes 357 429 1.76 (1.4, 2.3) 1.30 (0.8, 1.9) 0.278
No 108 232
Menopause age
>50 201 208 1.47 (1.1, 1.9) 1.41 (1.1, 1.9) 0.023
649 155 236
# Missing (326)
MHT (estrogen-only)
Yes 100 182 0.72 (0.6–0.9) 0.74 (0.6–0.9) 0.001
No 357 467
# Missing (20)
Age hysterectomy
640 43 67 0.52 (0.5, 0.9) 0.44 (0.2, 0.8) 0.020
41–49 45 69 0.53 (0.3–1.0) 0.45 (0.2–0.9) 0.023
P50 31 25 Referent Referent
# Missing (846)
(continued on next page)
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Table 2 (Continued)
Oral contraceptives
Yes 224 357 0.77 (0.6, 0.9) 0.78 (0.6, 0.9) 0.053
No 238 292
# Missing (15)
Age oral contraceptives
<20 41 88 0.72 (0.5, 1.1) 0.62 (0.4, 0.9) 0.048
P21 168 259
# Missing (570)
Abbreviations: BC, breast cancer; CI, confidence interval; OR, odds ratio; MHT, menopause hormone therapy.
a Adjusted by age, BMI, family history of breast cancer, menopause, number of children, alcohol use, smoking, vitamin use.
210 L. Morales et al.Almost all women in this study who had a history
of MHT treatment reported the use of estrogen-
only MHT (98.6%) because it is the most popular
MHT treatment that Puerto Rican physicians
prescribe. The findings of MHT being a potential
protective factor for BC need to be studied further;
the literature indicates that increased risk of BC
contributable to MHT treatment is due to a formu-
lation that combines estrogen with progestin [22].
The use of estrogen-only MHT has a less clear ef-
fect on BC risk [23]. Elevated estrogen levels found
in women with both ovaries and those going
through late menopause are at least partly respon-
sible for those women having BC some time in their
lives.
In addition, this study showed that women who
had a hysterectomy and/or an oophorectomy had
lower odds of having BC. It was also found that wo-
men who have a hysterectomy at an advanced age
have an increased risk of BC. This association could
be explained by a longer lifetime exposure to
estrogens and other hormones that have been
found to be associated with BC [24].
An increased number of pregnancies and a youn-
ger age at a full-term pregnancy decreased the risk
of BC. Changes in gene expression have been ob-
served in breast tissue of parous women compared
with nulliparous women [25], thus providing a
rationale for pregnancy-related protection against
BC.
The protective effect found in breastfeeding
women did not reach statistical significance due
to the reduced number of women who reported
breastfeeding for a prolonged period of time
(P6 months). This finding is particularly important
because of the cultural decline in the prevalence of
breastfeeding in Puerto Rican women [26]. Breast-
feeding, like some endometriosis treatments, de-
creases estrogen levels, thus helping to decrease
the risk of BC in premenopausal women. A longerduration of breastfeeding delays reestablishment
of ovulation after pregnancy, thus decreasing the
cumulative ovulatory menstrual cycles.
Having a family history of BC and/or any type of
cancer increases the odds of a woman having BC.
Relatives share genes, lifestyles, and environmen-
tal factors that collectively may influence their
health and their risk of developing BC.
Higher education was associated with decreased
BC risk; women who stopped their education at a
relatively low level (i.e., elementary school) were
at higher risk for BC when compared with those
who had at least an associate degree [27]. This
association is controversial because some studies
attribute a high educational level to high risk of
BC [27], while others present the opposite [28].
Changes in social and lifestyle patterns due to
widowhood or divorce appear to have an impact
on BC risk [29], and these results support that: both
widows and divorcees had higher odds of having BC
compared with married women. Widows tend to be
older women (aging is a risk factor in BC) and more
prone to depression and stress caused by the loss of
a spouse.
An increased risk in BC in Puerto Rican women
who smoke cigarettes was also observed. A number
of studies have suggested that smoking increases
the risk of BC [2], but this relationship is still con-
troversial. Further studies are required to confirm
this finding in the population studied.
The odds of having BC increased with age [2]. It
was found that in this population, women between
the ages of 40 and 61 years of age should be
screened more frequently for BC.
In agreement with other publications [30], this
study found that BC risk increases as BMI increases.
However, our results did not reach statistical sig-
nificance. That may be due to the similarity in
BMI among cases and controls, mean BMI (±SD) of
27.9 ± 5.5 and controls 27.3 ± 5.0 (P = 0.081), 66%
Table 3 Association of breast cancer with DRC, family history of cancer and breast cancer, obesity, lifestyle, ma al status and level of education.
Variable BC cases Controls Crude OR (95% CI) Adjusted ORa (95% CI) P value
DRCb
Low <2.52 279 101 14.86 (10.3–21.4) 17.32 (12.2–26.7) <0.001
Medium 2.53–5.36 122 252 2.44 (1.7–3.4) 2.7 (1.8–4.0) <0.001
High > 5.37 61 306 Referent Referent
# Missing (5)
Age
21–40 53 118 Referent Referent
41–60 238 376 2.32 (1.6–3.3) 1.78 (1.0–3.0) 0.036
61+ 174 167 1.65 (1.3–2.1) 1.41 (1.0–1.9) 0.024
BMI
Up to 24.99 327 422 1.26 (0.9–1.7) 1.06 (0.8–1.4) 0.788
P25 142 231
# Missing (4)
Smoke
(more than
100 cigarettes
in a lifetime)
Yes 58 59 1.44 (0.9–2.1) 1.58 (0.9–2.5) 0.066
No 405 594
# Missing (10)
Alcohol
Yes 68 113 0.82 (0.6–1.1) 0.99 (0.6–1.3) 0.556
No 394 538
# Missing (13)
Current vitamin
consumption
Yes 228 418 0.55 (0.4–0.7) 0.55 (0.4–0.7) <0.001
No 227 229
# Missing (24)
Vitamins
last 5 years
Yes 247 440 0.57 (0.4–0.7) 0.58 (0.4–0.8) <0.001
(continued on next page)
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No 208 210
# Missing (21)
Multivitamins
Yes 134 256 0.64 (0.5–0.8) 0.65 (0.5–0.9) 0.005
No 320 393
# Missing (23)
Calcium
Yes 86 181 0.60 (0.5–0.8) 0.52 (0.4–0.7) <0.001
No 368 467
# Missing (24)
Marital status
Married 227 435 Referent Referent
Divorced 103 116 3.59 (2.1–5.8) 2.57 (1.4–4.4) 0.002
Single 54 79 2.11 (1.2–3.6) 1.36 (0.7–2.6) 0.421
Widow 46 24 2.74 (1.5–5.0) 2.08 (1.1–4.0) 0.039
# Missing (42)
Education
1–8 31 10 5.77 (2.9–11.7) 3.38 (1.5–7.5) 0.003
9–12 146 174 1.72 (1.3–2.2) 1.33 (0.9–.9) 0.086
Associate or higher
Degree 218 445 Referent Referent
# Missing (102)
Family history of
cancer (not BC)
Yes 305 384 1.37 (1.1–1.8) 1.35 (1.0–1.8) 0.031
No 160 277
BC history in any family
member
Yes 134 121 1.81 (1.4–2.4) 2.00 (1.4–2.7) <0.001
No 331 540
Abbreviations: BC, breast cancer; CI, confidence interval; DRC, DNA repair capacity; BMI, body mass index.
a Adjusted by age, BMI, family history of breast cancer, menopause, number of children, alcohol use, smoking, vitamin use.
b DRC low (up to 2.50%), medium (2.51–5.50%), and high (5.51% and higher).
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obese. This may be due to self-reported weight and
height, which could potentially increase random
error and variability, leading to an underestimation
of the real association.
5. Public health relevance
Despite the fact that BC is the #1 cancer in Puerto
Rican women, limited research has been done
regarding its treatment and prevention on the is-
land. This study is the first to use a large cohort
of women to identify important protective and risk
factors for this population. Because some of these
risk factors are modifiable, the knowledge gained
from this study has practical applications in terms
of modifying public health policy for further BC
prevention. State public policy regarding cancer
control is influenced by the Puerto Rico Cancer
Registry. However, the Registry currently only col-
lects epidemiological data; it does not analyze or
publish population studies.
Thus, this study provides additional critical data
required for a more effective BC control plan.
Some of the findings can help public health person-
nel target high-risk populations, like those with low
levels of education, and create programs to help
young women adopt healthier lifestyles/habits that
will decrease their risk of BC. Education and out-
reach to help women implement simple, low-cost
risk reduction strategies, including breastfeeding,
exercise, and use of multivitamins and calcium
(as reported by Vergne et al., 2013 [31]) can
change the face of BC statistics in PR and can pos-
sibly provide the basis for risk-reduction models for
other populations. In addition, the possibility of
widespread use of a simple, non-invasive blood test
for DRC is appealing, as currently no such screening
test is available.6. Limitations
Because of the case-control nature of the study,
the temporal and causal associations could not be
determined; however, that was minimized because
incident cases were recruited in this study. Another
limitation in this study could be recall bias; how-
ever, an attempt was made to minimize this limita-
tion by relying on recall of current exposures.
Selection bias is also a frequent problem in this
type of study, but the selection procedures mini-
mized it. Control subjects consist of women re-
cruited from the same locations from which the
cases were recruited; if those controls were todevelop BC eventually, they would almost certainly
be treated in the same clinics from which the cases
were recruited [32]. Thus, the selection proce-
dures reduced the bias that otherwise may have
been caused by differences in the mode of select-
ing BC patients and control participants [17]. The
two main criteria for selecting all controls were
that all participants within the last 6 months prior
to enrollment [15] had been examined by their pri-
mary physicians (normal clinical breast examina-
tion) and had undergone a mammogram that
produced negative results. Those criteria reduced
the possibility of the existence of undiagnosed BC
among the controls [27]. It is possible that some
of the associations (around 5%) and their statistical
significance levels are artifactual due to a poten-
tially inflated type I error. This problem is espe-
cially important for weak associations. Therefore,
weak and borderline significant associations should
be interpreted with caution as they may not be
associated with the outcomes under study. Further
studies on the Puerto Rican population are needed
to confirm these results.
7. Conclusions
This study provides an overview of the major risk
factors for BC in PR. These results support that
family history of cancer or BC, low level of educa-
tion and aging increase the risk of developing BC.
However, this study shows a decreased risk in wo-
men with endometriosis, full-term pregnancy at
an earlier age, higher parity, and longer duration
of breastfeeding.
BC pathobiology is multifactorial and many risk
factors have been published. While efforts con-
tinue for finding a cure for BC, researchers should
concurrently intensify efforts in providing early
interventions: implementing programs to mitigate
modifiable risk factors, and utilizing knowledge of
genetic susceptibly to identify high-risk women to
perform earlier BC screening, and diagnosing BC
at an earlier stage. All these efforts should be tar-
gets for public health interventions.
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